Evidence map›Paper›PMID 38003887›Full record

ArticleJournal of personalized medicine2023

The Impact of Chronic Kidney Disease on the Mortality Rates of Patients with Urological Cancers-An Analysis of a Uro-Oncology Database from Eastern Europe.

Mircea Ciorcan, Șerban Negru, Răzvan Bardan, Alin Cumpănaș, Iasmina Mattar, Yahya Bitar, Lazăr Chișavu, Luciana Marc, Adalbert Schiller, Adelina Mihăescu

Open access · goldAbstract read
In one paragraph

Article in Journal of personalized medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 60% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Mircea CiorcanDepartment of Clinical Practical Skills, Victor Babes University of Medicine and Pharmacy, 300041 Timișoara, Romania.ORCID 0000-0002-8395-1009
Șerban NegruDepartment of Oncology, Victor Babes University of Medicine and Pharmacy, 300041 Timișoara, Romania.
Răzvan BardanDepartment of Urology, Victor Babes University of Medicine and Pharmacy, 300041 Timișoara, Romania.ORCID 0000-0002-8288-5468
Alin CumpănașDepartment of Urology, Victor Babes University of Medicine and Pharmacy, 300041 Timișoara, Romania.
Iasmina MattarDepartment of Urology, Clinical Emergency County Hospital, 300723 Timișoara, Romania.
Yahya BitarDepartment of Urology, Clinical Emergency County Hospital, 300723 Timișoara, Romania.ORCID 0000-0001-5373-7397
Lazăr ChișavuDepartment of Nephrology, Victor Babes University of Medicine and Pharmacy, 300041 Timișoara, Romania.
Luciana MarcDepartment of Nephrology, Victor Babes University of Medicine and Pharmacy, 300041 Timișoara, Romania.
Adalbert SchillerDepartment of Nephrology, Victor Babes University of Medicine and Pharmacy, 300041 Timișoara, Romania.
Adelina MihăescuDepartment of Nephrology, Victor Babes University of Medicine and Pharmacy, 300041 Timișoara, Romania.ORCID 0000-0002-3220-6623
Victor Babeș University of Medicine and Pharmacy Timișoara · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: The relationship between chronic kidney disease (CKD) and urological cancers is complex, as most of these cancers are diagnosed in patients with advanced ages, when the kidney function may be already impaired. On the other hand, urological cancers could represent a risk factor for CKD, significantly reducing the life expectancy of the patients. The main objective of our study was to analyze the impact of CKD on the overall mortality of patients diagnosed with the most frequent types of urological cancers. (2) Material and Methods: We conducted an observational retrospective cohort study on a group of 5831 consecutive newly diagnosed cancer patients, followed over a 2-year period (2019-2020), from a large Oncology Hospital in Romania. From this group, we selected only the patients diagnosed with urological malignancies, focusing on prostate cancer, bladder cancer and renal cancer; finally, 249 patients were included in our analysis. (3) Results: In the group of patients with prostate cancer (

Indexed as

bladder cancerchronic kidney diseaseoverall mortalityprostate cancerrenal cell carcinoma

Identifiers

PMID38003887
PMCPMC10672193
OpenAlexW4388296009

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.